FOLH1 and posterior cortical atrophy: Furthermore, the prognostic value of PSMA PET quantitation in the response assessment setting has been evaluated primarily in widespread metastatic PCa patients, often undergoing 177Lu-PSMA radioligand therapy16,17,20,22–24.